Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 98

1.

Peroxiredoxin 6 Is a Key Antioxidant Enzyme in Modulating the Link between Glycemic and Lipogenic Metabolism.

Arriga R, Pacifici F, Capuani B, Coppola A, Orlandi A, Scioli MG, Pastore D, Andreadi A, Sbraccia P, Tesauro M, Daniele ND, Sconocchia G, Donadel G, Bellia A, Della-Morte D, Lauro D.

Oxid Med Cell Longev. 2019 Dec 19;2019:9685607. doi: 10.1155/2019/9685607. eCollection 2019.

2.

European lipodystrophy registry: background and structure.

von Schnurbein J, Adams C, Akinci B, Ceccarini G, D'Apice MR, Gambineri A, Hennekam RCM, Jeru I, Lattanzi G, Miehle K, Nagel G, Novelli G, Santini F, Santos Silva E, Savage DB, Sbraccia P, Schaaf J, Sorkina E, Tanteles G, Vantyghem MC, Vatier C, Vigouroux C, Vorona E, Araújo-Vilar D, Wabitsch M.

Orphanet J Rare Dis. 2020 Jan 15;15(1):17. doi: 10.1186/s13023-020-1295-y.

3.

Gaps to bridge: Misalignment between perception, reality and actions in obesity.

Caterson ID, Alfadda AA, Auerbach P, Coutinho W, Cuevas A, Dicker D, Hughes C, Iwabu M, Kang JH, Nawar R, Reynoso R, Rhee N, Rigas G, Salvador J, Sbraccia P, Vázquez-Velázquez V, Halford JCG.

Diabetes Obes Metab. 2019 Aug;21(8):1914-1924. doi: 10.1111/dom.13752. Epub 2019 May 3.

4.

2-hydroxycaproate predicts cardiovascular mortality in patients with atherosclerotic disease.

Cardellini M, Ballanti M, Davato F, Cardolini I, Guglielmi V, Rizza S, Pecchioli C, Casagrande V, Mavilio M, Porzio O, Legramante JM, Ippoliti A, Farcomeni A, Sbraccia P, Menghini R, Dumas ME, Kappel BA, Federici M.

Atherosclerosis. 2018 Oct;277:179-185. doi: 10.1016/j.atherosclerosis.2018.06.014. Epub 2018 Jun 12.

PMID:
29958653
5.

Obesity phenotypes: depot-differences in adipose tissue and their clinical implications.

Guglielmi V, Sbraccia P.

Eat Weight Disord. 2018 Feb;23(1):3-14. doi: 10.1007/s40519-017-0467-9. Epub 2017 Dec 11. Review.

PMID:
29230714
6.

Obesity: focus on ongoing multidisciplinary and comprehensive research.

Sbraccia P, Nisoli E, Barazzoni R.

Eat Weight Disord. 2018 Feb;23(1):1. doi: 10.1007/s40519-017-0462-1. Epub 2017 Dec 11. No abstract available.

PMID:
29230713
7.

Parathyroid hormone in surgery-induced weight loss: no glucometabolic effects but potential adaptive response to skeletal loading.

Guglielmi V, Bellia A, Gentileschi P, Lombardo M, D'Adamo M, Lauro D, Sbraccia P.

Endocrine. 2018 Feb;59(2):288-295. doi: 10.1007/s12020-017-1477-0. Epub 2017 Nov 22.

PMID:
29168114
8.

Peroxiredoxin6, a Multitask Antioxidant Enzyme Involved in the Pathophysiology of Chronic Noncommunicable Diseases.

Pacifici F, Della Morte D, Capuani B, Pastore D, Bellia A, Sbraccia P, Di Daniele N, Lauro R, Lauro D.

Antioxid Redox Signal. 2019 Jan 20;30(3):399-414. doi: 10.1089/ars.2017.7427. Epub 2018 Jan 2.

PMID:
29160110
9.

Type 2 diabetes: Does pancreatic fat really matter?

Guglielmi V, Sbraccia P.

Diabetes Metab Res Rev. 2018 Feb;34(2). doi: 10.1002/dmrr.2955. Epub 2017 Oct 26. Review.

PMID:
28984071
10.

Drug interactions in users of tablet vs. oral liquid levothyroxine formulations: a real-world evidence study in primary care.

Guglielmi V, Bellia A, Bianchini E, Medea G, Cricelli I, Sbraccia P, Lauro D, Cricelli C, Lapi F.

Endocrine. 2018 Mar;59(3):585-592. doi: 10.1007/s12020-017-1412-4. Epub 2017 Sep 14.

PMID:
28905202
11.

Epicardial adipose tissue: at the heart of the obesity complications.

Guglielmi V, Sbraccia P.

Acta Diabetol. 2017 Sep;54(9):805-812. doi: 10.1007/s00592-017-1020-z. Epub 2017 Jun 29. Review.

PMID:
28664417
12.

Effectiveness of adherence to lipid lowering therapy on LDL-cholesterol in patients with very high cardiovascular risk: A real-world evidence study in primary care.

Guglielmi V, Bellia A, Pecchioli S, Della-Morte D, Parretti D, Cricelli I, Medea G, Sbraccia P, Lauro D, Cricelli C, Lapi F.

Atherosclerosis. 2017 Aug;263:36-41. doi: 10.1016/j.atherosclerosis.2017.05.018. Epub 2017 May 20.

PMID:
28599257
13.

MicroRNA 21 is up-regulated in adipose tissue of obese diabetic subjects.

Guglielmi V, D'Adamo M, Menghini R, Cardellini M, Gentileschi P, Federici M, Sbraccia P.

Nutr Healthy Aging. 2017 Mar 31;4(2):141-145. doi: 10.3233/NHA-160020.

14.

Sex-Genetic Interaction in the Risk for Cerebrovascular Disease.

Pastore D, Pacifici F, Capuani B, Palmirotta R, Dong C, Coppola A, Abete P, Roselli M, Sbraccia P, Guadagni F, Lauro D, Rundek T, Della-Morte D.

Curr Med Chem. 2017;24(24):2687-2699. doi: 10.2174/0929867324666170417100318. Review.

PMID:
28413964
15.

Healthcare usage and economic impact of non-treated obesity in Italy: findings from a retrospective administrative and clinical database analysis.

Colao A, Lucchese M, D'Adamo M, Savastano S, Facchiano E, Veronesi C, Blini V, Degli Esposti L, Sbraccia P.

BMJ Open. 2017 Feb 24;7(2):e013899. doi: 10.1136/bmjopen-2016-013899.

16.

GLP-1 receptor independent pathways: emerging beneficial effects of GLP-1 breakdown products.

Guglielmi V, Sbraccia P.

Eat Weight Disord. 2017 Jun;22(2):231-240. doi: 10.1007/s40519-016-0352-y. Epub 2016 Dec 31. Review.

PMID:
28040864
17.

Carbohydrates and insulin resistance in clinical nutrition: Recommendations from the ESPEN expert group.

Barazzoni R, Deutz NEP, Biolo G, Bischoff S, Boirie Y, Cederholm T, Cuerda C, Delzenne N, Leon Sanz M, Ljungqvist O, Muscaritoli M, Pichard C, Preiser JC, Sbraccia P, Singer P, Tappy L, Thorens B, Van Gossum A, Vettor R, Calder PC.

Clin Nutr. 2017 Apr;36(2):355-363. doi: 10.1016/j.clnu.2016.09.010. Epub 2016 Sep 19. Review.

PMID:
27686693
18.

2015 Milan Declaration: A Call to Action on Obesity - an EASO Position Statement on the Occasion of the 2015 EXPO.

Frühbeck G, Sbraccia P, Nisoli E, Woodward E, Yumuk V, Farpour-Lambert NJ, Halford JG, Toplak H, Carruba MO.

Obes Facts. 2016;9(4):296-8. doi: 10.1159/000448234. Epub 2016 Aug 30. No abstract available.

19.

What is the actual epidemiology of familial hypercholesterolemia in Italy? Evidence from a National Primary Care Database.

Guglielmi V, Bellia A, Pecchioli S, Medea G, Parretti D, Lauro D, Sbraccia P, Federici M, Cricelli I, Cricelli C, Lapi F.

Int J Cardiol. 2016 Nov 15;223:701-705. doi: 10.1016/j.ijcard.2016.08.269. Epub 2016 Aug 17.

PMID:
27568993
20.

The role of epsilon PKC in acute and chronic diseases: Possible pharmacological implications of its modulators.

Capuani B, Pacifici F, Pastore D, Palmirotta R, Donadel G, Arriga R, Bellia A, Di Daniele N, Rogliani P, Abete P, Sbraccia P, Guadagni F, Lauro D, Della-Morte D.

Pharmacol Res. 2016 Sep;111:659-667. doi: 10.1016/j.phrs.2016.07.029. Epub 2016 Jul 25. Review.

PMID:
27461137
21.

Relationship between Regional Fat Distribution and Hypertrophic Cardiomyopathy Phenotype.

Guglielmi V, Maresca L, Lanzillo C, Marinoni GM, D'Adamo M, Di Roma M, Preziosi P, Bellia A, Calò L, Sbraccia P.

PLoS One. 2016 Jul 7;11(7):e0158892. doi: 10.1371/journal.pone.0158892. eCollection 2016.

22.

SIO management algorithm for patients with overweight or obesity: consensus statement of the Italian Society for Obesity (SIO).

Santini F, Busetto L, Cresci B, Sbraccia P.

Eat Weight Disord. 2016 Jun;21(2):305-7. doi: 10.1007/s40519-016-0279-3. Epub 2016 Apr 21. No abstract available.

23.

Massive obesity and hyperphagia in posterior bilateral periventricular heterotopias: case report.

Guglielmi V, Floris R, D'Adamo M, Garaci F, Novelli G, Sbraccia P.

BMC Med Genet. 2016 Mar 9;17:18. doi: 10.1186/s12881-016-0282-6.

24.

Obstructive sleep apnoea as a risk factor for osteopenia and osteoporosis in the male population.

Liguori C, Mercuri NB, Izzi F, Romigi A, Cordella A, Piccirilli E, Viola S, Costa S, Sbraccia P, Marciani MG, Tarantino U, Placidi F.

Eur Respir J. 2016 Mar;47(3):987-90. doi: 10.1183/13993003.01830-2015. Epub 2016 Jan 7. No abstract available.

25.

Economic analysis of bedside ultrasonography (US) implementation in an Internal Medicine department.

Testa A, Francesconi A, Giannuzzi R, Berardi S, Sbraccia P.

Intern Emerg Med. 2015 Dec;10(8):1015-24. doi: 10.1007/s11739-015-1320-7. Epub 2015 Oct 8.

PMID:
26450846
26.

SGK-1 protects kidney cells against apoptosis induced by ceramide and TNF-α.

Pastore D, Della-Morte D, Coppola A, Capuani B, Lombardo MF, Pacifici F, Ferrelli F, Arriga R, Mammi C, Federici M, Bellia A, Di Daniele N, Tesauro M, Donadel G, Noto D, Sbraccia P, Sconocchia G, Lauro D.

Cell Death Dis. 2015 Sep 17;6:e1890. doi: 10.1038/cddis.2015.232.

27.

Role of Serum and Glucocorticoid-Inducible Kinase (SGK)-1 in Senescence: A Novel Molecular Target Against Age-Related Diseases.

Lauro D, Pastore D, Capuani B, Pacifici F, Palmirotta R, Abete P, Roselli M, Bellia A, Federici M, Di Daniele N, Sbraccia P, Guadagni F, Lauro R, Della-Morte D.

Curr Med Chem. 2015;22(33):3765-88. Review.

PMID:
26264924
28.

Omental adipose tissue fibrosis and insulin resistance in severe obesity.

Guglielmi V, Cardellini M, Cinti F, Corgosinho F, Cardolini I, D'Adamo M, Zingaretti MC, Bellia A, Lauro D, Gentileschi P, Federici M, Cinti S, Sbraccia P.

Nutr Diabetes. 2015 Aug 10;5:e175. doi: 10.1038/nutd.2015.22.

29.

Serum- and Glucocorticoid-Inducible Kinase 1 Delay the Onset of Endothelial Senescence by Directly Interacting with Human Telomerase Reverse Transcriptase.

Basello K, Pacifici F, Capuani B, Pastore D, Lombardo MF, Ferrelli F, Coppola A, Donadel G, Arriga R, Sconocchia G, Bellia A, Rogliani P, Federici M, Sbraccia P, Lauro D, Della-Morte D.

Rejuvenation Res. 2016 Feb;19(1):79-89. doi: 10.1089/rej.2015.1726.

PMID:
26230157
30.

Iron status in obesity: An independent association with metabolic parameters and effect of weight loss.

Guglielmi V, D'Adamo M, Bellia A, Ciotto RT, Federici M, Lauro D, Sbraccia P.

Nutr Metab Cardiovasc Dis. 2015 Jun;25(6):541-7. doi: 10.1016/j.numecd.2015.02.012. Epub 2015 Mar 4.

PMID:
25843660
31.

Modulation of TGFbeta 2 levels by lamin A in U2-OS osteoblast-like cells: understanding the osteolytic process triggered by altered lamins.

Evangelisti C, Bernasconi P, Cavalcante P, Cappelletti C, D'Apice MR, Sbraccia P, Novelli G, Prencipe S, Lemma S, Baldini N, Avnet S, Squarzoni S, Martelli AM, Lattanzi G.

Oncotarget. 2015 Apr 10;6(10):7424-37.

32.

Liver protein profiles in insulin receptor-knockout mice reveal novel molecules involved in the diabetes pathophysiology.

Capuani B, Della-Morte D, Donadel G, Caratelli S, Bova L, Pastore D, De Canio M, D'Aguanno S, Coppola A, Pacifici F, Arriga R, Bellia A, Ferrelli F, Tesauro M, Federici M, Neri A, Bernardini S, Sbraccia P, Di Daniele N, Sconocchia G, Orlandi A, Urbani A, Lauro D.

Am J Physiol Endocrinol Metab. 2015 May 1;308(9):E744-55. doi: 10.1152/ajpendo.00447.2014. Epub 2015 Feb 24.

33.

Pharmacogenomics and pharmacogenetics of thiazolidinediones: role in diabetes and cardiovascular risk factors.

Della-Morte D, Palmirotta R, Rehni AK, Pastore D, Capuani B, Pacifici F, De Marchis ML, Dave KR, Bellia A, Fogliame G, Ferroni P, Donadel G, Cacciatore F, Abete P, Dong C, Pileggi A, Roselli M, Ricordi C, Sbraccia P, Guadagni F, Rundek T, Lauro D.

Pharmacogenomics. 2014 Dec;15(16):2063-82. doi: 10.2217/pgs.14.162. Review.

34.

Age-related different relationships between ectopic adipose tissues and measures of central obesity in sedentary subjects.

Guglielmi V, Maresca L, D'Adamo M, Di Roma M, Lanzillo C, Federici M, Lauro D, Preziosi P, Bellia A, Sbraccia P.

PLoS One. 2014 Jul 22;9(7):e103381. doi: 10.1371/journal.pone.0103381. eCollection 2014.

35.

Serum glucocorticoid inducible kinase (SGK)-1 protects endothelial cells against oxidative stress and apoptosis induced by hyperglycaemia.

Ferrelli F, Pastore D, Capuani B, Lombardo MF, Blot-Chabaud M, Coppola A, Basello K, Galli A, Donadel G, Romano M, Caratelli S, Pacifici F, Arriga R, Di Daniele N, Sbraccia P, Sconocchia G, Bellia A, Tesauro M, Federici M, Della-Morte D, Lauro D.

Acta Diabetol. 2015 Feb;52(1):55-64. doi: 10.1007/s00592-014-0600-4. Epub 2014 Jun 25.

PMID:
24961472
36.

Peroxiredoxin 6, a novel player in the pathogenesis of diabetes.

Pacifici F, Arriga R, Sorice GP, Capuani B, Scioli MG, Pastore D, Donadel G, Bellia A, Caratelli S, Coppola A, Ferrelli F, Federici M, Sconocchia G, Tesauro M, Sbraccia P, Della-Morte D, Giaccari A, Orlandi A, Lauro D.

Diabetes. 2014 Oct;63(10):3210-20. doi: 10.2337/db14-0144. Epub 2014 Jun 19.

37.

Morning meal more efficient for fat loss in a 3-month lifestyle intervention.

Lombardo M, Bellia A, Padua E, Annino G, Guglielmi V, D'Adamo M, Iellamo F, Sbraccia P.

J Am Coll Nutr. 2014;33(3):198-205. doi: 10.1080/07315724.2013.863169. Epub 2014 May 8.

PMID:
24809437
38.

From simplicity towards complexity: the Italian multidimensional approach to obesity.

Donini LM, Dalle Grave R, Caretto A, Lucchin L, Melchionda N, Nisoli E, Sbraccia P, Lenzi A, Cuzzolaro M.

Eat Weight Disord. 2014;19(3):387-94. doi: 10.1007/s40519-013-0097-9. Epub 2014 Jan 22. Review. Erratum in: Eat Weight Disord. 2014 Sep;19(3):395.

PMID:
24448995
39.

Effects of whole body vibration plus diet on insulin-resistance in middle-aged obese subjects.

Bellia A, Sallì M, Lombardo M, D'Adamo M, Guglielmi V, Tirabasso C, Giordani L, Federici M, Lauro D, Foti C, Sbraccia P.

Int J Sports Med. 2014 Jun;35(6):511-6. doi: 10.1055/s-0033-1354358. Epub 2013 Nov 13.

PMID:
24227120
40.

An in-frame deletion at the polymerase active site of POLD1 causes a multisystem disorder with lipodystrophy.

Weedon MN, Ellard S, Prindle MJ, Caswell R, Lango Allen H, Oram R, Godbole K, Yajnik CS, Sbraccia P, Novelli G, Turnpenny P, McCann E, Goh KJ, Wang Y, Fulford J, McCulloch LJ, Savage DB, O'Rahilly S, Kos K, Loeb LA, Semple RK, Hattersley AT.

Nat Genet. 2013 Aug;45(8):947-50. doi: 10.1038/ng.2670. Epub 2013 Jun 16.

41.

Safety and efficacy of insulin aspart and soluble human insulin in Type 2 diabetes mellitus.

Cucinotta D, Caputo S, Mannucci E, Nicolucci A, Pellegrini F, Perriello G, Sbraccia P.

Minerva Endocrinol. 2012 Dec;37(4):357-66.

PMID:
23235191
42.

Parathyroid hormone and insulin resistance in distinct phenotypes of severe obesity: a cross-sectional analysis in middle-aged men and premenopausal women.

Bellia A, Marinoni G, D'Adamo M, Guglielmi V, Lombardo M, Donadel G, Gentileschi P, Lauro D, Federici M, Lauro R, Sbraccia P.

J Clin Endocrinol Metab. 2012 Dec;97(12):4724-32. doi: 10.1210/jc.2012-2513. Epub 2012 Oct 1.

PMID:
23027922
43.

The empowerment of translational research: lessons from laminopathies.

Benedetti S, Bernasconi P, Bertini E, Biagini E, Boriani G, Capanni C, Carboni N, Cenacchi G, Columbaro M, D'Adamo M, D'Amico A, D'Apice MR, Fontana M, Gambineri A, Lattanzi G, Liguori R, Maraldi NM, Mazzanti L, Mercuri E, Mongini T, Morandi LO, Neri I, Nigro G, Novelli G, Ortolani M, Pasquali R, Pini A, Petrini S, Politano L, Previtali S, Pucci L, Rapezzi C, Ricci G, Rodolico C, Sbraccia P, Scarano E, Siciliano G, Squarzoni S, Toscano A, Vercelli L, Ziacchi M.

Orphanet J Rare Dis. 2012 Jun 12;7:37.

44.

Deterioration of glucose homeostasis in type 2 diabetic patients one year after beginning of statins therapy.

Bellia A, Rizza S, Lombardo MF, Donadel G, Fabiano R, Andreadi K, Quon MJ, Sbraccia P, Federici M, Tesauro M, Cardillo C, Lauro D.

Atherosclerosis. 2012 Jul;223(1):197-203. doi: 10.1016/j.atherosclerosis.2012.04.015. Epub 2012 May 8.

PMID:
22658255
45.

TIMP3 overexpression in macrophages protects from insulin resistance, adipose inflammation, and nonalcoholic fatty liver disease in mice.

Menghini R, Casagrande V, Menini S, Marino A, Marzano V, Hribal ML, Gentileschi P, Lauro D, Schillaci O, Pugliese G, Sbraccia P, Urbani A, Lauro R, Federici M.

Diabetes. 2012 Feb;61(2):454-62. doi: 10.2337/db11-0613. Epub 2012 Jan 6.

46.

Overexpression of tissue inhibitor of metalloproteinase 3 in macrophages reduces atherosclerosis in low-density lipoprotein receptor knockout mice.

Casagrande V, Menghini R, Menini S, Marino A, Marchetti V, Cavalera M, Fabrizi M, Hribal ML, Pugliese G, Gentileschi P, Schillaci O, Porzio O, Lauro D, Sbraccia P, Lauro R, Federici M.

Arterioscler Thromb Vasc Biol. 2012 Jan;32(1):74-81. doi: 10.1161/ATVBAHA.111.238402. Epub 2011 Oct 20.

PMID:
22015660
47.

Decreased IRS2 and TIMP3 expression in monocytes from offspring of type 2 diabetic patients is correlated with insulin resistance and increased intima-media thickness.

Cardellini M, Menghini R, Luzi A, Davato F, Cardolini I, D'Alfonso R, Gentileschi P, Rizza S, Marini MA, Porzio O, Lauro D, Sbraccia P, Lauro R, Federici M.

Diabetes. 2011 Dec;60(12):3265-70. doi: 10.2337/db11-0162. Epub 2011 Oct 7.

48.

The growing role of bariatric surgery in the management of type 2 diabetes: evidences and open questions.

Busetto L, Sbraccia P, Frittitta L, Pontiroli AE.

Obes Surg. 2011 Sep;21(9):1451-7. doi: 10.1007/s11695-011-0471-5. Review.

PMID:
21717182
49.

Serum 25-hydroxyvitamin D levels are inversely associated with systemic inflammation in severe obese subjects.

Bellia A, Garcovich C, D'Adamo M, Lombardo M, Tesauro M, Donadel G, Gentileschi P, Lauro D, Federici M, Lauro R, Sbraccia P.

Intern Emerg Med. 2013 Feb;8(1):33-40. doi: 10.1007/s11739-011-0559-x. Epub 2011 Mar 25.

PMID:
21437585
50.

Sildenafil reduces insulin-resistance in human endothelial cells.

Mammi C, Pastore D, Lombardo MF, Ferrelli F, Caprio M, Consoli C, Tesauro M, Gatta L, Fini M, Federici M, Sbraccia P, Donadel G, Bellia A, Rosano GM, Fabbri A, Lauro D.

PLoS One. 2011 Jan 28;6(1):e14542. doi: 10.1371/journal.pone.0014542.

Supplemental Content

Loading ...
Support Center